Mr. Lowe was appointed the Company’s Vice President of Commercial Operations in June of 2021 and promoted to SVP, Commercial Operations in October of 2024. He brings more than 30 years of executive sales and marketing leadership in pharmaceutical, device and capital equipment sales, clinical applications, and business development at Aerie Pharmaceuticals, Inc., Carl Zeiss Meditec, AcuFocus, Boston Scientific, and INSPIRE Pharmaceuticals, Inc.

Most recently he was the Director of U.S. Sales, followed by Director of Marketing, and executed corporate strategic initiatives as well as strategic planning for the company’s worldwide glaucoma and ocular hypertension franchise.

Mr. Lowe has led multiple commercial launches with novel technologies for the treatment of presbyopia, glaucoma, dry eye, bacterial conjunctivitis, and myopia. He has a proven track record of success in strategic franchise growth, specializing in securing products in the marketplace, and building high performing sales teams in start-up environments.

Mr. Lowe holds a B.Sc. degree in Psychology and Economics from the University of California, Irvine.